Furthermore, miR-221–3p has been reported to regulate NSCLC cell proliferation and migration, as well as cisplatin resistance, by targeting the Suppressor of Cytokine Signaling 3 (SOCS3). The gene discussed is SOCS3; the disease is non-small cell lung carcinoma.